1. |
Aicardi J, Goutières F. A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann Neurol, 1984, 15(1): 49-54.
|
2. |
Merchant R, Verma M, Shah A, et al. Aicardi-Goutieres syndrome. Indian J Pediatr, 2016, 83(8): 882-883.
|
3. |
Abdel-Salam GMH, Abdel-Hamid MS, Mohammad SA, et al. Aicardi-Goutieres syndrome: unusual neuro-radiological manifestations. Metab Brain Dis, 2017, 32(3): 679-683.
|
4. |
Livingston JH, Crow YJ. Neurologic phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutieres syndrome and beyond. Neuropediatrics, 2016, 47(6): 355-360.
|
5. |
Li P, Du J, Goodier JL, et al. Aicardi-Goutieres syndrome protein TREX1 suppresses L1 and maintains genome integrity through exonuclease-independent ORF1p depletion. Nucleic Acids Res, 2017, 45(8): 4619-4631.
|
6. |
Schmelzer L, Smitka M, Wolf C, et al. Variable clinical phenotype in two siblings with Aicardi-Goutieres syndrome type 6 and a novel mutation in the ADAR gene. Eur J Paediatr Neurol, 2018, 22(1): 186-189.
|
7. |
Hall JC, Rosen A. Type I interferons: crucial participants in disease amplification in autoimmunity. Nat Rev Rheumatol, 2010, 6(1): 40-49.
|
8. |
Li M, Zhang D, Zhu M, et al. Roles of SAMHD1 in antiviral defense, autoimmunity and cancer. Rev Med Virol, 2017, 27(4).
|
9. |
Krageloh-Mann I. Characterisation of Aicardi-Goutieres syndrome. Lancet Neurol, 2013, 12(12): 1131-1132.
|
10. |
Ramantani G, Maillard LG, Bast T, et al. Epilepsy in Aicardi-Goutieres syndrome. Eur J Paediatr Neurol, 2014, 18(1): 30-37.
|
11. |
Al Mutairi F, Alfadhel M, Nashabat M, et al. Phenotypic and molecular spectrum of Aicardi-Goutieres syndrome: a study of 24 patients. Pediatr Neurol, 2018, 78: 35-40.
|
12. |
Luo S, Wang Y, Zhao M, et al. The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus. Int Immunopharmacol, 2016, 40: 542-549.
|
13. |
Henrickson M, Wang H. Tocilizumab reverses cerebral vasculopathy in a patient with homozygous SAMHD1 mutation. Clin Rheumatol, 2017, 36(6): 1445-1451.
|